Figure 1
Study design of the SCLEROCYST trial. AS, aspiration and sclerotherapy; INJ, injection of pasireotide or placebo; Q, assessment of GIS-, PLD- and SF-36 questionnaires; US, ultrasonography.
Figure 1 | Trials
Study design of the SCLEROCYST trial. AS, aspiration and sclerotherapy; INJ, injection of pasireotide or placebo; Q, assessment of GIS-, PLD- and SF-36 questionnaires; US, ultrasonography.
Trials